Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, and abdominal pain
GLP-1s can also mess a little with your gut microbiome, possibly favoring bacteria that produce more sulfur gases
If your BMI is over 27 and you have obesity-related conditions like osteoarthritis, high blood pressure, diabetes, high cholesterol, cardiovascular disease, or metabolic syndrome issues such as fatty liver, youre also eligible
Studies have shown that there is a bidirectional relationship between NAFLD and type 2 diabetes, and that NAFLD may precede and/or promote the development of type 2 diabetes [2, 3]
Le smaglutide est un mdicament de plus en plus utilis pour le traitement du diabte de type 2 et de l'obsit
Or, as a normal frequency, in a group of 10,508 people on semaglutide, it prevented 29 heart attacks over an average follow-up time of 1.32 years